Search Results - "LIU, Yingqiu Y"
-
1
Reduction of TRAIL-Induced Mcl-1 and cIAP2 by c-Myc or Sorafenib Sensitizes Resistant Human Cancer Cells to TRAIL-Induced Death
Published in Cancer cell (01-07-2007)“…Cells expressing oncogenic c-Myc are sensitized to TNF superfamily proteins. c-Myc also is an important factor in determining whether a cell is sensitive to…”
Get full text
Journal Article -
2
Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: Evidence for the role of c-Jun N-terminal kinase activation
Published in Cell cycle (Georgetown, Tex.) (01-09-2012)“…The discovery of the molecular targets of chemotherapeutic medicines and their chemical footprints can validate and improve the use of such medicines. In the…”
Get full text
Journal Article -
3
Noninvasive vascular imaging in fluorescent tumors using multispectral unmixing
Published in BioTechniques (01-10-2008)“…Noninvasive imaging of tumor vascularization in animal models provides an important tool for studying the biology of tumor angiogenesis as well as monitoring…”
Get full text
Journal Article -
4
Utility of Dual-modality Bioluminescence and MRI in Monitoring Stem Cell Survival and Impact on Post Myocardial Infarct Remodeling
Published in Academic radiology (2011)“…Rationale and Objectives Firefly luciferase (Fluc) reporter gene is an authentic marker for surviving stem cells. However, it is unable to visualize the…”
Get full text
Journal Article -
5
The Myc-miR-17∼92 Axis Blunts TGFβ Signaling and Production of Multiple TGFβ-Dependent Antiangiogenic Factors
Published in Cancer research (Chicago, Ill.) (15-10-2010)“…c-Myc stimulates angiogenesis in tumors through mechanisms that remain incompletely understood. Recent work indicates that c-Myc upregulates the miR-17∼92…”
Get full text
Journal Article -
6
Cell cycle-dependent and schedule-dependent antitumor effects of sorafenib combined with radiation
Published in Cancer research (Chicago, Ill.) (01-10-2007)“…The antineoplastic drug sorafenib (BAY 43-9006) is a multikinase inhibitor that targets the serine-threonine kinase B-Raf as well as several tyrosine kinases…”
Get full text
Journal Article -
7
Overcoming Hypoxia-Induced Apoptotic Resistance through Combinatorial Inhibition of GSK-3β and CDK1
Published in Cancer research (Chicago, Ill.) (01-08-2011)“…Tumor hypoxia is an inherent impediment to cancer treatment that is both clinically significant and problematic. In this study, we conducted a cell-based…”
Get full text
Journal Article -
8
Abstract 3625: A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary (CUP) using circulating tumor cells
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Metastasis is responsible for the majority of cancer-related deaths. A limiting step in metastasis is access to circulation, thus circulating tumor cells…”
Get full text
Journal Article -
9
Myc - miR-17~92 axis blunts TGFβ signaling and production of multiple TGFβ-dependent anti-angiogenic factors
Published in Cancer research (Chicago, Ill.) (12-10-2010)“…c-Myc stimulates angiogenesis in tumors through mechanisms that remain incompletely understood. Recent work indicates that c-Myc upregulates the miR-17~92…”
Get full text
Journal Article -
10
The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors
Published in Cancer research (Chicago, Ill.) (15-10-2010)“…c-Myc stimulates angiogenesis in tumors through mechanisms that remain incompletely understood. Recent work indicates that c-Myc upregulates the miR-17∼92…”
Get full text
Journal Article